Journal of Enzyme Inhibition and Medicinal Chemistry · 2021 · 41 citations · 51 references
MedicineMedicinal ChemistryPharmacologyDrug DiscoveryMolecular OncologyMolecular PharmacologyEnzyme InhibitionOncology PharmacologyTopoisomerase InhibitorsTyrosine Kinase InhibitorsAnticancer ActivityAntiproliferative AgentsAntiproliferative Drug ActionBiological Evaluation ReportEgfr InhibitionTopoisomerase I Inhibitors
s = 22.68, 14.25, 18.36, 17.36, and 15.36 nM, respectively). Finally, molecular modelling was employed to justify the promising EGFR/FAK inhibition. The study outcomes afforded the first reported quinolines with potent EGFR/FAK dual inhibition.
51